Sex hormones and adipocytokines in postmenopausal women;Hormony płciowe i adipocytokiny u kobiet po menopauzie

Polski Merkuriusz Lekarski

Volumn 20, Issue 120, 2006, Pages 727-730

  Siemińska, Lucyna ^a   Cichoń Lenart, Agata ^a   Kajdaniuk, Dariusz ^a   Kos Kudła, Beata ^a   Marek, Bogdan ^a   Lenart, Jarosław ^a   Nowak, Mariusz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adipocytokines; Postmenopausal obesity; Sex hormones; Visceral fat

Indexed keywords

ADIPOCYTOKINE; ANDROGEN; FAT; LEPTIN; RESISTIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADIPOCYTE; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN SENSITIVITY; LIPID OXIDATION; MENOPAUSE; METABOLIC DISORDER; NONHUMAN; OVARIECTOMY; POSTMENOPAUSE; PROTEIN EXPRESSION; REVIEW;

ADIPONECTIN; ANDROGENS; CYTOKINES; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; LEPTIN; MIDDLE AGED; POSTMENOPAUSE; RESISTIN;

EID: 33746150046     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Adeghate E.: An update on the biology and physiology of resistin. Cell Mol. Life Sci., 2004, 61, 2485-96.
2. Combs T.P., Berg A.H., Rajala M.W., i wsp.: Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes, 2003, 52, 268-76.
3. Ferrara C.M., Lynch N.A., Nicklas B.J., i wsp.: Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J. Clin. Endocrinol. Metab., 2002, 87, 4166-70.
4. Fukuhara A., Matsuda M., Nishizawa M., i wsp.: Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307, 426-30.
5. Garaulet M., Perez-Llamas F., Fuente T. i wsp.: Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur. J. Endocirnol., 2000, 143. 657-66.
6. Gower B.A., Nagy T.R., Goran M.I. i wsp.: Leptin in postmenopausal women: influence of hormone therapy, insulin and fat. J. Clin. Endocrinol. Metab., 2000, 85, 1770-5.
7. Gregoraszczuk E.L., Wojtowicz A.K., Ptak A. i wsp.: In vitro effect of leptin on steroids secretion by FSH- and LH-treatedporcine small, medium and large, preovulatory follicles. Reprod. Biol., 2003, 3, 227-39.
8. Gui Y, Silha J.V., Murphy L.J.: Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res., 2004, 12, 1481-91.
9. Hajamor S., Despres J.P., Couillard C. i wsp.: Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism, 2003, 52, 724-30.
10. Kalish G.M., Barrett-Connor E., Laughlin G.A., i wsp.: Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the postmenopausal estrogen/progestin intervention trial. J. Clin. Endocrinol. Metab., 2003, 88, 1646-52.
11. Karelis A.D., St-Pierre D.H., Conus F. i wsp.: Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab., 2004, 89, 2569-75.
12. Kershaw E.E., Flier J.S.: Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89, 2548-56.
13. Kusminski C.M., McTernan P.G., Kumar S.: Role of resistin in obesity, insulin resistance and type II diabetes. Clin. Sci., 2005, 109, 243-56.
14. Leyva F., Godsland I.F., Ghatei M. i wsp.: Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Art. Thromb. Vasc. Biology, 1998, 18, 928-33.
15. Ling C., Kindblom J., Wennbo H. i wsp.: Increased resisitn expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett., 2001, 507, 147-50.
16. Machinal-Quelin F., Dieudonne M.N., Pecquery R. i wsp.: Direct in vitro effects of androgens and estrogens on ob gene expression and leptin secretion in human adipose tissue. Endocrine, 2002, 18, 179-84.
17. Meli R., Pacilio M., Raso G.M. i wsp.: Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology, 2004, 145, 3115-21.
18. Messinis I.E., Milingos S.D., Alexandris E. i wsp.: Leptin concentrations in normal women following bilateral ovariectomy. Hum. Reprod., 1999, 14, 913-8.
19. Milewicz A., Zatońska K., Demissie M. i wsp.: Serum adiponectin concentration and cardiovascular risk factors in climacteric women. Gynecol. Endocrinol., 2005, 20, 68-73.
20. Nishizawa H., Shimomura I., Kishida K. i wsp.: Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes, 2002, 51, 2734-41.
21. Piche M.E., Weisnagel S.J., Corneau L. i wsp.: Contribution of abdominal visceral obesity and insulin resistance to the cardiovascular risk profile of postmenopausal women. Diabetes. 2005, 54, 770-7.
22. Rajala M.W., Obici S., Scherer P.E. i wsp.: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Invest., 111, 2003, 111, 225-230.
23. Reinecke H., Bogdanski J., Woltering A. i wsp.: Relation of serum levels of sex hormone binding globulin to coronary heart disease in postmenopausal women. Am. J. Cardiol., 2002, 90, 364-8.
24. Shimizu H., Shimomura Y., Nakanishi Y. i wsp.: Estrogen increases in vivo leptin production in rats and human subjects. J. Endocrinol., 1997, 154, 285-92.
25. Sieminska L., Marek B., Kajdaniuk D. i wsp.: Adiponektyna - ogniwo ła̧cza̧ce otyłość, miażdż ycȩ i cukrzycȩ. Pol. Arch. Med. Wewn., 2002, 18, 1245-51.
26. Siemińska L., Wojciechowska C., Niedziołka D. i wsp.: Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolizm, 2005, (w przygotowaniu do druku.
27. Tanko L.B., Bruun J.M., Alexandersen P. i wsp.: Novel associations between bioavailable estradiol and adipokines in elderly women with different phenotypes of obesity. Circulation, 2004, 110, 2246-52.
28. Van Beek A., de Ruijter-Heijstek C., Jansen H. i wsp.: Sex steroids and plasma lipoprotein levels in healthy women: the importance of androgens in the estrogen-deficient state. Metabolism, 2004, 53, 187-92.